Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)

Central Pharmaceuticals Cash Flow Statement

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	-36.36	-42.42	-43.96	-68.25	-8.47	-1,107
Depreciation & Amortization	24.04	24.04	26.75	29.76	32.89	36.28
Other Amortization	0.01	0.01	0.01	0.01	-	-
Asset Writedown & Restructuring Costs	10.59	10.59	-	-	-	-
Other Operating Activities	-9.61	-3.04	0.01	17.47	21.32	1,070
Change in Accounts Receivable	7.14	7.14	-1.3	-0.05	-23.03	-
Change in Inventory	3.8	3.8	17.12	20.58	-7.41	-
Change in Accounts Payable	4.21	4.21	3.79	0.85	-1.39	-
Change in Income Taxes	0.18	0.18	0.18	0.16	0.89	-
Change in Other Net Operating Assets	4.5	4.5	1.16	1.07	-5.95	-
Operating Cash Flow	2.46	2.97	-0.33	-1.12	1.8	-0.41
Capital Expenditures	-	-	-	-	-6.57	-
Investing Cash Flow	-	-	-	-	-6.57	-
Short-Term Debt Issued	-	-	-	9.12	-	8.3
Long-Term Debt Issued	-	-	-	7.92	25.21	12.49
Total Debt Issued	-	-	-	17.04	25.21	20.78
Net Debt Issued (Repaid)	-	-	-	17.04	25.21	20.78
Common Dividends Paid	-	-	-	-	-	-11.98
Other Financing Activities	-0.01	-0.01	-0.01	-17.47	-21.45	-9.98
Financing Cash Flow	-0.01	-0.01	-0.01	-0.43	3.76	-1.18
Net Cash Flow	2.45	2.96	-0.34	-1.55	-1.02	-1.59
Free Cash Flow	2.46	2.97	-0.33	-1.12	-4.78	-0.41
Free Cash Flow Margin	35.00%	10.02%	-1.11%	-4.31%	-3.22%	-0.29%
Free Cash Flow Per Share	0.02	0.03	-0.00	-0.01	-0.04	-0.00
Cash Interest Paid	-	-	-	17.36	21.36	9.95
Cash Income Tax Paid	0	0	0.35	0.11	5.95	9.08
Levered Free Cash Flow	15.4	14.59	17.79	8.19	-19.67	278.09
Unlevered Free Cash Flow	15.4	14.59	17.79	19.04	-6.32	284.31
Change in Working Capital	13.78	13.78	16.86	19.89	-43.95	-

Updated Dec 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.